Twist Bioscience Corp cotiza a 151.33 USD y tiene una capitalización bursátil de $10.0B. En los últimos 12 meses ha facturado $432M con un margen de flujo de caja libre del -20.1%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. It offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial …
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.56 | $-0.60 | $-0.50 |
| Estimado | $-0.15 | $-0.28 | $-0.53 | $-0.52 |
| Sorpresa | — | -100.0% | -13.2% | +3.8% |
| Métrica | TWST | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 50.7% | 57.0% | -6.3% |
| Operating Margin | -36.2% | -38.6% | +2.4% |
| Net Margin | -20.6% | -33.6% | +12.9% |
| FCF Margin | -20.1% | -13.9% | -6.2% |
| ROE | -16.4% | -40.4% | +24.0% |
| ROA | -12.1% | -32.0% | +19.9% |
| Current Ratio | 3.64 | 2.84 | +0.80 |
| Debt / Equity | — | 0.28 | — |